HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Pedro J. del Nido Peter C. Laussen Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Odegard, K. C. Articles by Laussen, P. C. Search for Related Content PubMed PubMed Citation Articles by Odegard, K. C. Articles by Laussen, P. C. Related Collections Congenital - cyanotic

J Thorac Cardiovasc Surg 2003;125:1260-1267
© 2003 The American Association for Thoracic Surgery

Surgery for Congenital Heart Disease

Procoagulant and anticoagulant factor abnormalities following the Fontan procedure: Increased factor VIII may predispose to thrombosis

From the Departments of Anesthesia, Cardiac Surgery, and Biostatistics, Children's Hospital, Boston, and Harvard Medical School, Boston, Mass.

Received for publication April 25, 2002. Revisions received July 17, 2002. Accepted for publication Aug 27, 2002. Address for reprints: Kirsten C. Odegard, MD, Cardiac Anesthesia Service, 300 Longwood Avenue, Children's Hospital, Boston, MA 02115 (E-mail: kirsten.odegard{at}tch.harvard.edu).

Objective: Using age-matched controls, this study prospectively evaluated coagulation factor abnormalities and hemodynamic variables in children who had undergone the Fontan operation.
Methods: Coagulation factors were assayed in 20 children (mean age 6.4 ± 2.9 years), at a mean 3.7 ± 2.3 years after the Fontan procedure; 24 healthy children (mean age 6.8 ± 2.8 years) were assayed as controls. Concentration of factors II, V, VII, VIII, IX, X; ATIII; plasminogen; proteins C and S; fibrinogen; serum albumin; and liver enzymes were measured. Normal reference intervals based on the control patients were determined using 95% confidence limits. Patient demographic, hemodynamic variables, and elapsed time after the Fontan procedure were evaluated as possible predictors of coagulation abnormalities.
Results: Concentrations of protein C; factors II, V, VII, X; plasminogen; and ATIII were significantly lower in Fontan patients compared with age-matched controls (P < .01); factor VIII was significantly elevated in 6 patients (35%), 2 of whom had a thromboembolic event. A higher superior vena cava pressure was predictive of an elevated factor VIII level (P = .003). No other specific hemodynamic variables were predictive of a procoagulant or anticoagulant abnormality.
Conclusion: Procoagulant and anticoagulant factor levels were significantly lower in patients after the Fontan operation independent of hemodynamic variables peculiar to the Fontan circulation. Increased factor VIII level requires further evaluation as a cause of thrombosis in patients with Fontan physiology and may also indicate a subset of these patients in whom anticoagulation is indicated.